WHAT THE C@H?! Trademark

Trademark Overview


On Monday, February 26, 2024, a trademark application was filed for WHAT THE C@H?! with the United States Patent and Trademark Office. The USPTO has given the WHAT THE C@H?! trademark a serial number of 98421393. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, August 28, 2024. This trademark is owned by Neurocrine Biosciences, Inc.. The WHAT THE C@H?! trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Promoting awareness of congenital adrenal hyperplasia and providing a public platform to discuss congenital adrenal hyperplasia and coping strategies; Promoting awareness of adrenal insufficiency and providing a public platform to discuss adrenal insufficiency and coping strategies; Promoting awareness of endocrine diseases and disorders and providing a public platform to discuss endocrine diseases and disorders and coping strategies; promoting the interests of people who have congenital adrenal hyperplasia and their families and health care providers by means of public advocacy; promoting the interests of people who have adrenal insufficiency and their families and health care providers by means of public advocacy; promoting the interests of people who have endocrine diseases and disorders and their families and health care providers by means of public advocacy; maintaining a registry of patients with congenital adrenal hyperplasia; maintaining a registry of patients with adrenal insu...

Providing medical information; providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia; providing medical information to patients, medical professionals, and insurance companies in the field of adrenal insufficiency; providing medical information to patients, medical professionals, and insurance companies in the field of endocrine diseases and disorders; online information services, namely, providing medical information in the field of congenital adrenal hyperplasia; online information services, namely, providing medical information in the field of adrenal insufficiency; online information services, namely, providing medical information in the field of endocrine diseases and disorders; Providing an in-person health forum for users to participate in discussions in the field of congenital adrenal hyperplasia; Providing an in-person health forum for users to participate in discussions in the field of adrenal ...

Providing information about medical research; providing medical research information in the field of pharmaceuticals and congenital adrenal hyperplasia; providing medical research information in the field of pharmaceuticals and adrenal insufficiency; providing medical research information in the field of pharmaceuticals and endocrine diseases and disorders
what the c@h?!

General Information


Serial Number98421393
Word MarkWHAT THE C@H?!
Filing DateMonday, February 26, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, August 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the words WHAT THE C@H?!, with "WHAT THE" being within a trapezoid above "C@H?!" which is also in a trapezoid.
Pseudo MarkWHAT THE C AT H
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPromoting awareness of congenital adrenal hyperplasia and providing a public platform to discuss congenital adrenal hyperplasia and coping strategies; Promoting awareness of adrenal insufficiency and providing a public platform to discuss adrenal insufficiency and coping strategies; Promoting awareness of endocrine diseases and disorders and providing a public platform to discuss endocrine diseases and disorders and coping strategies; promoting the interests of people who have congenital adrenal hyperplasia and their families and health care providers by means of public advocacy; promoting the interests of people who have adrenal insufficiency and their families and health care providers by means of public advocacy; promoting the interests of people who have endocrine diseases and disorders and their families and health care providers by means of public advocacy; maintaining a registry of patients with congenital adrenal hyperplasia; maintaining a registry of patients with adrenal insufficiency; maintaining a registry of patients with endocrine diseases and disorders; updating and maintenance of information in registries, namely, administering a patient registry for patients with congenital adrenal hyperplasia; updating and maintenance of information in registries, namely, administering a patient registry for patients with adrenal insufficiency; updating and maintenance of information in registries, namely, administering a patient registry for patients with endocrine diseases and disorders
Goods and ServicesProviding medical information; providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia; providing medical information to patients, medical professionals, and insurance companies in the field of adrenal insufficiency; providing medical information to patients, medical professionals, and insurance companies in the field of endocrine diseases and disorders; online information services, namely, providing medical information in the field of congenital adrenal hyperplasia; online information services, namely, providing medical information in the field of adrenal insufficiency; online information services, namely, providing medical information in the field of endocrine diseases and disorders; Providing an in-person health forum for users to participate in discussions in the field of congenital adrenal hyperplasia; Providing an in-person health forum for users to participate in discussions in the field of adrenal insufficiency; Providing an in-person health forum for users to participate in discussions in the field of endocrine diseases and disorders
Goods and ServicesProviding information about medical research; providing medical research information in the field of pharmaceuticals and congenital adrenal hyperplasia; providing medical research information in the field of pharmaceuticals and adrenal insufficiency; providing medical research information in the field of pharmaceuticals and endocrine diseases and disorders

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, February 26, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 26, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 26, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Monday, February 26, 2024NEW APPLICATION ENTERED
Sunday, May 5, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, May 5, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 15, 2024ASSIGNED TO EXAMINER
Wednesday, August 28, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 28, 2024NON-FINAL ACTION WRITTEN
Wednesday, August 28, 2024NON-FINAL ACTION E-MAILED
Tuesday, November 12, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, November 12, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED